T_NNP Ten_CD million_CD people_NNS en_IN million_CD people_NNS wer_VBP were_VBD tr_NN e_SYM treated_VBN against_IN lymphatic_JJ filariasis_NN eated_VBN against_IN lymphatic_JJ filariasis_NN in_IN one_CD day_NN in_IN one_CD day_NN Global_NNP Community_NNP Partnerships_NNS Through_IN its_PRP$ Global_NNP Community_NNP Partnerships_NNS function_NN ,_, GSK_NNP partners_NNS with_IN and_CC supports_VBZ organizations_NNS whose_WP$ goals_NNS and_CC objectives_NNS reflect_VBP its_PRP$ mission_NN of_IN improving_VBG the_DT quality_NN of_IN human_JJ life_NN ._.
In_IN just_RB one_CD day_NN ..._: Lymphatic_NNP filariasis_VBZ The_DT Groups_NNS flagship_NN program_NN is_VBZ its_PRP$ role_NN in_IN the_DT Global_JJ Alliance_NNP to_TO Eliminate_VB Lymphatic_NNP Filariasis_NNP ,_, one_CD of_IN the_DT Administration_NNP Day_NNP ._.
The_DT people_NNS of_IN Sri_NNP Lanka_NNP will_MD not_RB forget_VB Sunday_NNP ,_, 27th_JJ July_NNP ,_, 2003_CD ._.
On_IN that_DT Elimination_NN by_IN 2020_CD The_DT goals_NNS of_IN this_DT partnership_NN with_IN Since_IN 1998_CD ,_, the_DT Group_NNP has_VBZ pharmaceutical_JJ industrys_NNS An_DT estimated_VBN 120_CD million_CD people_NNS the_DT WHO_WP and_CC other_JJ organizations_NNS supplied_VBD a_DT total_NN of_IN 240_CD million_CD day_NN ,_, ten_CD million_CD people_NNS nearly_RB half_NN of_IN the_DT countrys_NNS population_NN received_VBD free_JJ tablets_NNS to_TO help_VB prevent_VB largest_JJS donation_NN programs_NNS ._.
are_VBP affected_VBN by_IN LF_NNP ,_, a_DT tropical_JJ disease_NN are_VBP to_TO interrupt_VB the_DT transmission_NN free_JJ albendazole_NN treatments_NNS ._.
the_DT transmission_NN of_IN lymphatic_JJ filariasis_NN LF_NNP ,_, a_DT disfiguring_NN disease_NN also_RB known_VBN as_IN elephantiasis_NN ._.
More_JJR than_IN HIV_NNP AIDS_NNP Through_IN its_PRP$ Positive_JJ that_WDT has_VBZ plagued_VBN humanity_NN with_IN of_IN LF_NNP ,_, country_NN by_IN country_NN ,_, until_IN it_PRP In_IN addition_NN to_TO donating_VBG drugs_NNS ,_, Action_NNP program_NN ,_, GSK_NNP works_VBZ immense_JJ suffering_NN ,_, social_JJ stigma_NN has_VBZ been_VBN eliminated_VBN as_IN a_DT public_JJ GSK_NNP provides_VBZ significant_JJ financial_JJ 50,000_CD healthcare_NN workers_NNS and_CC volunteers_NNS distributed_VBN GSK-donated_JJ albendazole_NN and_CC other_JJ tablets_NNS to_TO in_IN partnership_NN with_IN individuals_NNS and_CC severe_JJ disability_NN for_IN thousands_NNS health_NN problem_NN ._.
This_DT is_VBZ expected_VBN resources_NNS and_CC staff_NN expertise_NN to_TO people_NNS living_VBG in_IN areas_NNS where_WRB LF_NNP is_VBZ endemic_JJ ._.
It_PRP was_VBD one_CD of_IN the_DT largest_JJS mass_NN administrations_NNS of_IN its_PRP$ type_NN to_TO and_CC groups_NNS at_IN the_DT community_NN of_IN years_NNS ._.
A_DT further_JJ one_CD billion_CD to_TO take_VB 20_CD years_NNS ._.
support_NN coalition_NN building_NN ,_, advocacy_NN ,_, have_VBP taken_VBN place_NN in_IN the_DT developing_VBG world_NN ._.
But_CC our_PRP$ efforts_NNS against_IN the_DT spread_NN of_IN LF_NNP did_VBD not_RB stop_VB there_RB ._.
level_NN to_TO pursue_VB more_JJR effective_JJ people_NNS in_IN 80_CD countries_NNS are_VBP at_IN research_NN ,_, community_NN mobilisation_NN HIV_NNP prevention_NN ,_, education_NN and_CC risk_NN of_IN infection_NN ._.
GSKs_NNS antiparasitic_JJ albendazole_NN is_VBZ and_CC educational_JJ initiatives_NNS ._.
In_IN 2003_CD ,_, through_IN our_PRP$ partnership_NN with_IN the_DT World_NNP Health_NNP Organization_NNP WHO_WP ,_, we_PRP donated_VBD 94_CD million_CD support_NN for_IN people_NNS living_VBG with_IN ,_, used_VBN with_IN one_CD of_IN two_CD other_JJ drugs_NNS treatments_NNS of_IN albendazole_NN to_TO 34_CD countries_NNS worth_JJ 11_CD million_CD ._.
We_PRP have_VBP committed_VBN to_TO provide_VB or_CC affected_VBN by_IN ,_, HIV_NNP AIDS_NNP ._.
The_DT mass_NN drug_NN administration_NN to_TO stop_VB the_DT transmission_NN of_IN LF_NNP ._.
The_DT Today_NN ,_, there_EX is_VBZ hope_NN that_IN a_DT new_JJ albendazole_JJ free_JJ of_IN charge_NN for_IN as_RB long_JJ as_IN it_PRP takes_VBZ to_TO eliminate_VB LF_NNP ._.
effort_NN in_IN Sri_NNP Lanka_NNP on_IN that_DT July_NNP Group_NNP donates_VBZ the_DT tablets_NNS to_TO the_DT generation_NN of_IN children_NNS will_MD have_VB Malaria_NNP The_DT GSK_NNP African_NNP day_NN was_VBD spectacular_JJ ,_, but_CC GSK_NNP WHO_WP which_WDT then_RB provides_VBZ them_PRP lives_VBZ free_JJ of_IN LF_NNP ._.
Malaria_NNP Partnership_NNP is_VBZ a_DT continues_VBZ to_TO help_VB in_IN a_DT long-term_JJ to_TO the_DT health_NN authorities_NNS of_IN affected_JJ community_NN partnership_NN which_WDT global_JJ program_NN to_TO eliminate_VB countries_NNS for_IN local_JJ distribution_NN ._.
The_DT aims_NNS to_TO develop_VB effective_JJ the_DT disease_NN through_IN its_PRP$ active_JJ mass_NN administration_NN day_NN in_IN Sri_NNP Lanka_NNP ,_, malaria_NN control_NN behaviors_NNS membership_NN of_IN the_DT Global_JJ Alliance_NNP for_IN example_NN ,_, was_VBD organised_VBN by_IN the_DT in_IN African_JJ communities_NNS ._.
